Miriam E. Tucker

February 9, 2012 | Oncology Practice Author and Disclosure Information A HEAD AND NECK CANCER SYMPOSIUM SPONSORED BY THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY

TOPLINE: Most society guidelines for physical activity (PA) for people with type 2 diabetes (T2D) generally align with recommendations for

TOPLINE: Higher body mass index (BMI) is associated with more thyroid nodules and worse fine-needle aspiration (FNA) outcomes. METHODOLOGY:

TOPLINE: In patients with type 2 diabetes (T2D) and ST-segment elevation myocardial infarction (STEMI) treated with percutaneous coronary

Reproductive endocrinology researcher Teresa K. Woodruff, PhD, has been awarded a National Medal of Science for her pioneering work in preserving fertility for people with cancer, among other achievements.

TOPLINE: Significant differences were observed in the cardio-metabolic protein profiles of women with vs without previous gestational diabetes

A Lancet Commission has redefined obesity by classifying it as either “clinical obesity,” a disease, or “preclinical,” a health risk factor, with the distinction based on factors beyond body mass index (BMI).

A Lancet Commission has provided new definitions for “clinical” and “preclinical” obesity, with the former being labelled the disease and the latter a condition of health risk.

TOPLINE: In a post-hoc analysis of five Eli Lilly-funded SURPASS trials, tirzepatide was associated with a greater urinary albumin-to-creatinine

The US Food and Drug Administration (FDA) approved semaglutide (Ozempic, Novo Nordisk) for reducing the risk for worsening kidney disease and cardiovascular death in adults with both type 2 diabetes and chronic kidney disease